Korean medical and healthcare companies have won innovation awards for the world's largest electronics exhibition, CES 2024, in Las Vegas next January. In particular, medical AI solution providers and digital therapeutic device (DTx) makers for diagnostic support dominated the awardee list.
The Consumer Technology Association (CTA), which organizes CES, selects products for innovation awards in each category by evaluating the innovation of the exhibited products, including technology, design, and customer value.
On Nov. 15 (local time), the CTA unveiled the CES Innovation Award-winning products and technologies for next year’s event at the Las Vegas Convention Center from Jan. 9 to 12.
Deep Bio, a medical artificial intelligence company, is the first Korean cancer diagnosis AI company to receive the CES Innovation Award. The award is in the digital health category, and the winning product and technology was DeepDx-Prostate, an AI prostate cancer severity analysis software.
"We will continue to improve the cancer diagnosis environment to overcome one of humanity's greatest challenges and provide medical professionals with cutting-edge cancer diagnosis AI solutions through unsparing investment in technology," Deep Bio CEO Kim Sun-woo said.
Another medical AI company, Waycen, became the triple medalist in the CES Innovation Awards. Waycen won three innovation awards for WAYMED Cough PRO and WAYMED Food Allergy. The company received two awards in the Artificial Intelligence category and one in the Software and Mobile Apps category.
"These awards signify the global recognition of Waycen's innovation in medical big data analysis technology," a Waycen official said. "Both are AI-based products developed through joint research with medical experts in their respective fields. They have great significance in the medical industry, as medical and AI experts have jointly developed clinically useful products with technical verification and achieved excellent results.
Waymed Cough Pro is an AI-based self-screening application that checks the user's respiratory health with three to five cough sounds. The service results from joint research with the research team of Professor Moon Kyung-min of the Department of Respiratory and Allergy Medicine at Chung-Ang University Hospital and Dr. Jeon Jin-hee (formerly director of Yonsei B&A Clinic).
Waymed Food Allergy is an AI-based customized food allergy oral immunotherapy digital treatment device for children and adolescents with food allergies. It results from joint research with the research team of Professors Ahn Kang-mo and Kim Ji-hyun of the Department of Allergy and Respiratory Medicine at Samsung Medical Center.
Exosystems received the Innovation Award for Digital Health for its customized healthcare solution based on MFI (muscle function index), a digital biomarker developed in-house. This is the company's second award in 2020.
Exosystems' personalized healthcare solution provides customized exercise interventions and neuromuscular electrical stimulation (NME) therapy based on biofeedback. The solution's digital therapy software analyzes the user's biofeedback in real-time to set customized exercise goals and difficulty levels.
"We are honored to receive the CES Innovation Award, which recognizes Exosystems' technology and business on a prestigious international stage. Our goal is to continue introducing innovative solutions that contribute to personalized medicine, targeting conditions with high unmet needs," CEO Lee Hoo-man said.
Synergy AI won the Innovation Award in the Digital Health category for its AI-powered predictive diagnostic solution for arrhythmias. Synergy AI's AI-based arrhythmia prediction diagnostic assistant, Mac'AI, is designed to identify when an irregular heartbeat occurs accurately. Professor Park Jun-beom of Ewha Womans University Mokdong Hospital participated in the development of Mac’AI.
Synergy AI CEO Shin Tae-young said, "We are delighted to receive the CES 2024 Innovation Award. We will promote Mac’AI as a CES 2024 participant to provide a breakthrough alternative to early diagnosis strategies for arrhythmia at home and abroad."
InBody won the Innovation Award in the Sports & Fitness category for its big data solution LB Trainer. This is the first time Inbody has won an award on the international stage for a big data solution rather than a hardware product, such as a body composition analyzer.
LB Trainer is a healthcare solution for personal trainers. Its main functions include AI body composition change prediction, posture measurement evaluation, and food detection and quantity estimation. In particular, AI body composition change prediction calculates muscle, fat, and circulation scores of the upper and lower body to predict body composition changes according to exercise intensity, type, and goal weekly.
"Big data solutions are pouring in all over the world, but InBody's solution is differentiated in that it is a big data healthcare solution directly accumulated through solid hardware," InBody Vice President Choi Chang-eun said. “Using this CES 2024 Innovation Award as a springboard, we will continue to improve our hardware technology and actively invest in expanding our body composition big data business to strengthen our value as a global healthcare company."